Human Serum 25-hydroxycholecalciferol Response to Extended Oral Dosing with Cholecalciferol
Overview
Affiliations
Background: The cholecalciferol inputs required to achieve or maintain any given serum 25-hydroxycholecalciferol concentration are not known, particularly within ranges comparable to the probable physiologic supply of the vitamin.
Objectives: The objectives were to establish the quantitative relation between steady state cholecalciferol input and the resulting serum 25-hydroxycholecalciferol concentration and to estimate the proportion of the daily requirement during winter that is met by cholecalciferol reserves in body tissue stores.
Design: Cholecalciferol was administered daily in controlled oral doses labeled at 0, 25, 125, and 250 micro g cholecalciferol for approximately 20 wk during the winter to 67 men living in Omaha (41.2 degrees N latitude). The time course of serum 25-hydroxycholecalciferol concentration was measured at intervals over the course of treatment.
Results: From a mean baseline value of 70.3 nmol/L, equilibrium concentrations of serum 25-hydroxycholecalciferol changed during the winter months in direct proportion to the dose, with a slope of approximately 0.70 nmol/L for each additional 1 micro g cholecalciferol input. The calculated oral input required to sustain the serum 25-hydroxycholecalciferol concentration present before the study (ie, in the autumn) was 12.5 micro g (500 IU)/d, whereas the total amount from all sources (supplement, food, tissue stores) needed to sustain the starting 25-hydroxycholecalciferol concentration was estimated at approximately 96 micro g (approximately 3800 IU)/d. By difference, the tissue stores provided approximately 78-82 micro g/d.
Conclusions: Healthy men seem to use 3000-5000 IU cholecalciferol/d, apparently meeting > 80% of their winter cholecalciferol need with cutaneously synthesized accumulations from solar sources during the preceding summer months. Current recommended vitamin D inputs are inadequate to maintain serum 25-hydroxycholecalciferol concentration in the absence of substantial cutaneous production of vitamin D.
Expert consensus on vitamin D in osteoporosis.
Lei S, Zhang X, Song L, Wen J, Zhang Z, Tian J Ann Jt. 2025; 10:1.
PMID: 39981430 PMC: 11836767. DOI: 10.21037/aoj-24-48.
Vitamin D: Evidence-Based Health Benefits and Recommendations for Population Guidelines.
Grant W, Wimalawansa S, Pludowski P, Cheng R Nutrients. 2025; 17(2).
PMID: 39861407 PMC: 11767646. DOI: 10.3390/nu17020277.
Wimalawansa S, Weiss S, Hollis B Nutrients. 2024; 16(22).
PMID: 39599755 PMC: 11597479. DOI: 10.3390/nu16223969.
Ghiga G, Tarca E, Tarca V, Spoiala E, Paduraru G, Gimiga N Nutrients. 2024; 16(22).
PMID: 39599595 PMC: 11597251. DOI: 10.3390/nu16223808.
Savolainen L, Timpmann S, Mooses M, Maestu E, Medijainen L, Lellsaar M Nutrients. 2024; 16(19).
PMID: 39408324 PMC: 11478703. DOI: 10.3390/nu16193356.